

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | actin-mediated cell contraction (GO:0070252) | 9.82844903 |
| 2 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 9.70779688 |
| 3 | skeletal muscle adaptation (GO:0043501) | 9.03237429 |
| 4 | sarcomere organization (GO:0045214) | 7.78065115 |
| 5 | plasma membrane repair (GO:0001778) | 7.63397249 |
| 6 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 7.42482469 |
| 7 | actin filament-based movement (GO:0030048) | 7.40766653 |
| 8 | skeletal muscle fiber development (GO:0048741) | 6.79699143 |
| 9 | striated muscle contraction (GO:0006941) | 6.74424927 |
| 10 | myofibril assembly (GO:0030239) | 6.72338307 |
| 11 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 6.60227226 |
| 12 | creatine metabolic process (GO:0006600) | 6.24741727 |
| 13 | carnitine shuttle (GO:0006853) | 6.20908629 |
| 14 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 6.14330947 |
| 15 | glycogen catabolic process (GO:0005980) | 6.03089236 |
| 16 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 5.90721422 |
| 17 | regulation of cell communication by electrical coupling (GO:0010649) | 5.80999424 |
| 18 | myotube cell development (GO:0014904) | 5.78133950 |
| 19 | striated muscle atrophy (GO:0014891) | 5.73173749 |
| 20 | skeletal muscle tissue regeneration (GO:0043403) | 5.63884472 |
| 21 | glucan catabolic process (GO:0009251) | 5.63584669 |
| 22 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 5.55569705 |
| 23 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 5.54228789 |
| 24 | response to inactivity (GO:0014854) | 5.50029841 |
| 25 | response to muscle activity (GO:0014850) | 5.31407679 |
| 26 | * muscle contraction (GO:0006936) | 5.28511217 |
| 27 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 5.26256746 |
| 28 | cellular polysaccharide catabolic process (GO:0044247) | 5.25363017 |
| 29 | cytidine metabolic process (GO:0046087) | 5.24202755 |
| 30 | cytidine catabolic process (GO:0006216) | 5.24202755 |
| 31 | cytidine deamination (GO:0009972) | 5.24202755 |
| 32 | fatty acid transmembrane transport (GO:1902001) | 5.20343486 |
| 33 | actomyosin structure organization (GO:0031032) | 5.19983534 |
| 34 | striated muscle adaptation (GO:0014888) | 5.15884542 |
| 35 | polysaccharide catabolic process (GO:0000272) | 4.99729933 |
| 36 | muscle atrophy (GO:0014889) | 4.95267019 |
| 37 | cardiac muscle contraction (GO:0060048) | 4.84091316 |
| 38 | purine nucleotide salvage (GO:0032261) | 4.83556042 |
| 39 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 4.77668829 |
| 40 | * muscle system process (GO:0003012) | 4.75061924 |
| 41 | regulation of relaxation of muscle (GO:1901077) | 4.73589752 |
| 42 | cardiac myofibril assembly (GO:0055003) | 4.72880793 |
| 43 | muscle fiber development (GO:0048747) | 4.71228071 |
| 44 | glycogen biosynthetic process (GO:0005978) | 4.69711355 |
| 45 | glucan biosynthetic process (GO:0009250) | 4.69711355 |
| 46 | carnitine transmembrane transport (GO:1902603) | 4.58083403 |
| 47 | muscle cell fate commitment (GO:0042693) | 4.54086524 |
| 48 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 4.52995398 |
| 49 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 4.37056320 |
| 50 | tricarboxylic acid cycle (GO:0006099) | 4.34459453 |
| 51 | regulation of coenzyme metabolic process (GO:0051196) | 4.30306548 |
| 52 | regulation of cofactor metabolic process (GO:0051193) | 4.30306548 |
| 53 | fructose metabolic process (GO:0006000) | 4.27332335 |
| 54 | IMP metabolic process (GO:0046040) | 4.21807475 |
| 55 | muscle adaptation (GO:0043500) | 4.21478275 |
| 56 | carnitine transport (GO:0015879) | 4.16555035 |
| 57 | amino-acid betaine transport (GO:0015838) | 4.16555035 |
| 58 | regulation of actin filament-based movement (GO:1903115) | 4.15020377 |
| 59 | muscle organ morphogenesis (GO:0048644) | 4.13130049 |
| 60 | glycogen metabolic process (GO:0005977) | 4.11899164 |
| 61 | cellular glucan metabolic process (GO:0006073) | 4.03320815 |
| 62 | glucan metabolic process (GO:0044042) | 4.03320815 |
| 63 | regulation of striated muscle contraction (GO:0006942) | 3.94259180 |
| 64 | gluconeogenesis (GO:0006094) | 3.92513063 |
| 65 | myoblast fusion (GO:0007520) | 3.88665835 |
| 66 | muscle hypertrophy (GO:0014896) | 3.88565024 |
| 67 | heart process (GO:0003015) | 3.86620999 |
| 68 | heart contraction (GO:0060047) | 3.86620999 |
| 69 | striated muscle cell development (GO:0055002) | 3.86400696 |
| 70 | cardiac muscle cell development (GO:0055013) | 3.84087657 |
| 71 | regulation of skeletal muscle cell differentiation (GO:2001014) | 3.82062590 |
| 72 | negative regulation of muscle hypertrophy (GO:0014741) | 3.77340592 |
| 73 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 3.70302235 |
| 74 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 3.68950797 |
| 75 | muscle organ development (GO:0007517) | 3.67239799 |
| 76 | regulation of sequestering of triglyceride (GO:0010889) | 3.65654285 |
| 77 | myotube differentiation (GO:0014902) | 3.64830934 |
| 78 | negative regulation of skeletal muscle tissue development (GO:0048642) | 3.62439116 |
| 79 | muscle structure development (GO:0061061) | 3.62302495 |
| 80 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 3.60642387 |
| 81 | regulation of calcium ion transmembrane transport (GO:1903169) | 3.60642387 |
| 82 | response to activity (GO:0014823) | 3.59634133 |
| 83 | cardiac cell development (GO:0055006) | 3.59017770 |
| 84 | muscle cell cellular homeostasis (GO:0046716) | 3.58203281 |
| 85 | hexose biosynthetic process (GO:0019319) | 3.51577919 |
| 86 | regulation of sulfur metabolic process (GO:0042762) | 3.47753358 |
| 87 | cardiac muscle hypertrophy in response to stress (GO:0014898) | 3.45866647 |
| 88 | muscle hypertrophy in response to stress (GO:0003299) | 3.45866647 |
| 89 | cardiac muscle adaptation (GO:0014887) | 3.45866647 |
| 90 | positive regulation of myotube differentiation (GO:0010831) | 3.44090010 |
| 91 | syncytium formation by plasma membrane fusion (GO:0000768) | 3.41775542 |
| 92 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 3.40753376 |
| 93 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 3.36677004 |
| 94 | negative regulation of cAMP-mediated signaling (GO:0043951) | 3.36259815 |
| 95 | cellular response to dexamethasone stimulus (GO:0071549) | 3.36000118 |
| 96 | striated muscle tissue development (GO:0014706) | 3.35686098 |
| 97 | negative regulation of muscle contraction (GO:0045932) | 3.34937108 |
| 98 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 3.33969973 |
| 99 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 3.33969973 |
| 100 | striated muscle hypertrophy (GO:0014897) | 3.33166225 |
| 101 | muscle cell development (GO:0055001) | 3.31468066 |
| 102 | regulation of myoblast differentiation (GO:0045661) | 3.30704004 |
| 103 | neuronal action potential propagation (GO:0019227) | 3.27605828 |
| 104 | skeletal muscle tissue development (GO:0007519) | 3.27564509 |
| 105 | 2-oxoglutarate metabolic process (GO:0006103) | 3.26658279 |
| 106 | cellular carbohydrate catabolic process (GO:0044275) | 3.26339349 |
| 107 | regulation of membrane repolarization (GO:0060306) | 3.24485038 |
| 108 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 3.23611405 |
| 109 | positive regulation of cation channel activity (GO:2001259) | 3.23550364 |
| 110 | IMP biosynthetic process (GO:0006188) | 3.20772379 |
| 111 | cardiac muscle hypertrophy (GO:0003300) | 3.18926498 |
| 112 | muscle tissue morphogenesis (GO:0060415) | 3.18309895 |
| 113 | NADH metabolic process (GO:0006734) | 3.16194770 |
| 114 | regulation of myotube differentiation (GO:0010830) | 3.15681176 |
| 115 | neuromuscular synaptic transmission (GO:0007274) | 3.14944562 |
| 116 | positive regulation of myoblast differentiation (GO:0045663) | 3.14793418 |
| 117 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 3.11803056 |
| 118 | cardiac muscle tissue morphogenesis (GO:0055008) | 3.11494848 |
| 119 | adult heart development (GO:0007512) | 3.10956735 |
| 120 | muscle filament sliding (GO:0030049) | 12.0189255 |
| 121 | actin-myosin filament sliding (GO:0033275) | 12.0189255 |
| 122 | regulation of skeletal muscle contraction (GO:0014819) | 11.4306794 |
| 123 | skeletal muscle contraction (GO:0003009) | 10.0575411 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 7.39594687 |
| 2 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.84245348 |
| 3 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 3.63867546 |
| 4 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 3.59949081 |
| 5 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 3.13841268 |
| 6 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 3.13841268 |
| 7 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 3.07140284 |
| 8 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.76683891 |
| 9 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 2.39845946 |
| 10 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 2.37673969 |
| 11 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.34537918 |
| 12 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 2.22794183 |
| 13 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.19019542 |
| 14 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 2.18995712 |
| 15 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.04806644 |
| 16 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.01196700 |
| 17 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.87254399 |
| 18 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.82716547 |
| 19 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.82573487 |
| 20 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.81996459 |
| 21 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.77666594 |
| 22 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.71062345 |
| 23 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.70279638 |
| 24 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.67431808 |
| 25 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.61485645 |
| 26 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.61375169 |
| 27 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.56615747 |
| 28 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.55007569 |
| 29 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.54067744 |
| 30 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 1.53362690 |
| 31 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.51187710 |
| 32 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.51029444 |
| 33 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.49487942 |
| 34 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.47920094 |
| 35 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.47708373 |
| 36 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.46325308 |
| 37 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.45372880 |
| 38 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.40608816 |
| 39 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.40268114 |
| 40 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.36678671 |
| 41 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.35427315 |
| 42 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.32304022 |
| 43 | CTCF_21964334_Chip-Seq_Bcells_Human | 1.31249704 |
| 44 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.30062515 |
| 45 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.29757697 |
| 46 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.29343505 |
| 47 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.28601553 |
| 48 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.28050615 |
| 49 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.27714795 |
| 50 | SA1_27219007_Chip-Seq_Bcells_Human | 1.27286586 |
| 51 | MAF_26560356_Chip-Seq_TH1_Human | 1.25607388 |
| 52 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 1.25161137 |
| 53 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.23907017 |
| 54 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.22463705 |
| 55 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.20678265 |
| 56 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.18671429 |
| 57 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 1.18137973 |
| 58 | OCT4_20526341_ChIP-Seq_ESCs_Human | 1.17053667 |
| 59 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.15948431 |
| 60 | P68_20966046_ChIP-Seq_HELA_Human | 1.15750842 |
| 61 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.15051778 |
| 62 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.14636541 |
| 63 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.14582026 |
| 64 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.12684300 |
| 65 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 1.11929166 |
| 66 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.11665890 |
| 67 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.10575643 |
| 68 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.10508519 |
| 69 | MYC_22102868_ChIP-Seq_BL_Human | 1.10369505 |
| 70 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.09633252 |
| 71 | TDRD3_21172665_ChIP-Seq_MCF-7_Human | 1.09606518 |
| 72 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.09325788 |
| 73 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.07810394 |
| 74 | * MYC_27129775_Chip-Seq_CORNEA_Mouse | 1.07727595 |
| 75 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.06866846 |
| 76 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.05948191 |
| 77 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.05592367 |
| 78 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.04606061 |
| 79 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 1.03650861 |
| 80 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.01202992 |
| 81 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.01131827 |
| 82 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.00416968 |
| 83 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.00034831 |
| 84 | ATF3_27146783_Chip-Seq_COLON_Human | 0.99930160 |
| 85 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.99697425 |
| 86 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.99609991 |
| 87 | E2F1_20622854_ChIP-Seq_HELA_Human | 0.99452389 |
| 88 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.97384518 |
| 89 | GATA1_22025678_ChIP-Seq_K562_Human | 0.97297573 |
| 90 | * STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.97030401 |
| 91 | * TP63_22573176_ChIP-Seq_HFKS_Human | 0.96783036 |
| 92 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.96727074 |
| 93 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.96720268 |
| 94 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 0.96648622 |
| 95 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.96340884 |
| 96 | * UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.95884029 |
| 97 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.94297612 |
| 98 | * EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.93230121 |
| 99 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.92901045 |
| 100 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.92314054 |
| 101 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.91364593 |
| 102 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.91048297 |
| 103 | * SPI1_20517297_ChIP-Seq_HL60_Human | 0.90965281 |
| 104 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.89965204 |
| 105 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.89670521 |
| 106 | KDM2B_26808549_Chip-Seq_K562_Human | 0.89588961 |
| 107 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.89509824 |
| 108 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.89018894 |
| 109 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.88565181 |
| 110 | PRDM14_21183938_ChIP-Seq_MESCs_Mouse | 0.88523896 |
| 111 | GATA1_19941826_ChIP-Seq_K562_Human | 0.88195568 |
| 112 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.88056865 |
| 113 | MAF_26560356_Chip-Seq_TH2_Human | 0.87859673 |
| 114 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.87367916 |
| 115 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.85694794 |
| 116 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.85642609 |
| 117 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.85399825 |
| 118 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.85381430 |
| 119 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.84801094 |
| 120 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.84716819 |
| 121 | * SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.82784869 |
| 122 | DPY_21335234_ChIP-Seq_ESCs_Mouse | 0.82562779 |
| 123 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.80809722 |
| 124 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 0.80539163 |
| 125 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.80433286 |
| 126 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.79201989 |
| 127 | GATA3_21867929_ChIP-Seq_CD8_Mouse | 0.78361462 |
| 128 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.77870853 |
| 129 | * SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.77064587 |
| 130 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.76745631 |
| 131 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.76544302 |
| 132 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.76101463 |
| 133 | TP53_23651856_ChIP-Seq_MEFs_Mouse | 0.73419627 |
| 134 | CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 0.73294760 |
| 135 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.72996832 |
| 136 | * GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.72607710 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004145_abnormal_muscle_electrophysio | 7.29856077 |
| 2 | MP0000749_muscle_degeneration | 6.51208568 |
| 3 | * MP0000751_myopathy | 5.03687124 |
| 4 | MP0002837_dystrophic_cardiac_calcinosis | 4.91433786 |
| 5 | * MP0003646_muscle_fatigue | 4.40299795 |
| 6 | * MP0002106_abnormal_muscle_physiology | 4.13403561 |
| 7 | * MP0004036_abnormal_muscle_relaxation | 3.87759172 |
| 8 | * MP0000747_muscle_weakness | 3.80131302 |
| 9 | * MP0000759_abnormal_skeletal_muscle | 3.73655672 |
| 10 | * MP0004087_abnormal_muscle_fiber | 3.64615438 |
| 11 | MP0000750_abnormal_muscle_regeneration | 3.50134487 |
| 12 | MP0004130_abnormal_muscle_cell | 3.48337816 |
| 13 | * MP0005369_muscle_phenotype | 3.42803025 |
| 14 | * MP0002269_muscular_atrophy | 3.35091469 |
| 15 | * MP0005620_abnormal_muscle_contractility | 3.20825044 |
| 16 | MP0004084_abnormal_cardiac_muscle | 2.85836848 |
| 17 | MP0004233_abnormal_muscle_weight | 2.76578108 |
| 18 | MP0005330_cardiomyopathy | 2.64823527 |
| 19 | MP0004215_abnormal_myocardial_fiber | 2.37237720 |
| 20 | MP0000733_abnormal_muscle_development | 2.32377860 |
| 21 | MP0002332_abnormal_exercise_endurance | 2.24939949 |
| 22 | MP0006036_abnormal_mitochondrial_physio | 2.05318118 |
| 23 | MP0002108_abnormal_muscle_morphology | 1.95383450 |
| 24 | MP0002972_abnormal_cardiac_muscle | 1.88655981 |
| 25 | MP0004484_altered_response_of | 1.79151373 |
| 26 | MP0010630_abnormal_cardiac_muscle | 1.76493758 |
| 27 | MP0004185_abnormal_adipocyte_glucose | 1.74707946 |
| 28 | MP0005666_abnormal_adipose_tissue | 1.62212358 |
| 29 | MP0003221_abnormal_cardiomyocyte_apopto | 1.51663703 |
| 30 | MP0001544_abnormal_cardiovascular_syste | 1.44026518 |
| 31 | MP0005385_cardiovascular_system_phenoty | 1.44026518 |
| 32 | MP0002971_abnormal_brown_adipose | 1.35126665 |
| 33 | MP0003137_abnormal_impulse_conducting | 1.34229116 |
| 34 | MP0001661_extended_life_span | 1.31871064 |
| 35 | MP0005375_adipose_tissue_phenotype | 1.25768194 |
| 36 | MP0008775_abnormal_heart_ventricle | 1.15427168 |
| 37 | MP0003950_abnormal_plasma_membrane | 1.14214647 |
| 38 | MP0005266_abnormal_metabolism | 1.10670047 |
| 39 | MP0000013_abnormal_adipose_tissue | 1.08983745 |
| 40 | MP0006035_abnormal_mitochondrial_morpho | 1.07811098 |
| 41 | MP0003806_abnormal_nucleotide_metabolis | 1.03438366 |
| 42 | MP0004270_analgesia | 1.01036446 |
| 43 | MP0004510_myositis | 0.97649516 |
| 44 | MP0002822_catalepsy | 0.96489333 |
| 45 | MP0006138_congestive_heart_failure | 0.95618955 |
| 46 | MP0005670_abnormal_white_adipose | 0.95466588 |
| 47 | MP0008961_abnormal_basal_metabolism | 0.94951655 |
| 48 | MP0002234_abnormal_pharynx_morphology | 0.93060731 |
| 49 | MP0003705_abnormal_hypodermis_morpholog | 0.89789112 |
| 50 | MP0003828_pulmonary_edema | 0.87063153 |
| 51 | MP0002127_abnormal_cardiovascular_syste | 0.85044941 |
| 52 | MP0000003_abnormal_adipose_tissue | 0.79075702 |
| 53 | MP0000266_abnormal_heart_morphology | 0.78236705 |
| 54 | MP0009780_abnormal_chondrocyte_physiolo | 0.78127025 |
| 55 | MP0004085_abnormal_heartbeat | 0.75755370 |
| 56 | MP0000343_altered_response_to | 0.72712111 |
| 57 | MP0003879_abnormal_hair_cell | 0.69820226 |
| 58 | MP0004147_increased_porphyrin_level | 0.68864195 |
| 59 | MP0003656_abnormal_erythrocyte_physiolo | 0.67896787 |
| 60 | MP0005334_abnormal_fat_pad | 0.67382278 |
| 61 | MP0002078_abnormal_glucose_homeostasis | 0.66853624 |
| 62 | MP0004043_abnormal_pH_regulation | 0.65486442 |
| 63 | MP0004134_abnormal_chest_morphology | 0.62287536 |
| 64 | MP0005167_abnormal_blood-brain_barrier | 0.54397874 |
| 65 | MP0010030_abnormal_orbit_morphology | 0.53301753 |
| 66 | MP0003045_fibrosis | 0.52108954 |
| 67 | MP0008569_lethality_at_weaning | 0.50962711 |
| 68 | MP0001299_abnormal_eye_distance/ | 0.50071292 |
| 69 | MP0005275_abnormal_skin_tensile | 0.49950813 |
| 70 | MP0003567_abnormal_fetal_cardiomyocyte | 0.48156192 |
| 71 | MP0000762_abnormal_tongue_morphology | 0.46855921 |
| 72 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.46335645 |
| 73 | MP0002638_abnormal_pupillary_reflex | 0.45803203 |
| 74 | MP0000372_irregular_coat_pigmentation | 0.45087552 |
| 75 | MP0005452_abnormal_adipose_tissue | 0.44867531 |
| 76 | MP0000230_abnormal_systemic_arterial | 0.42737968 |
| 77 | MP0009250_abnormal_appendicular_skeleto | 0.42573394 |
| 78 | MP0002128_abnormal_blood_circulation | 0.42138260 |
| 79 | MP0005319_abnormal_enzyme/_coenzyme | 0.41167041 |
| 80 | MP0009115_abnormal_fat_cell | 0.40823528 |
| 81 | MP0001853_heart_inflammation | 0.40454016 |
| 82 | MP0005083_abnormal_biliary_tract | 0.37477348 |
| 83 | MP0003948_abnormal_gas_homeostasis | 0.36921655 |
| 84 | MP0003959_abnormal_lean_body | 0.35919353 |
| 85 | MP0001879_abnormal_lymphatic_vessel | 0.35528746 |
| 86 | MP0001346_abnormal_lacrimal_gland | 0.33895232 |
| 87 | MP0002896_abnormal_bone_mineralization | 0.33858204 |
| 88 | MP0002734_abnormal_mechanical_nocicepti | 0.33499335 |
| 89 | MP0002249_abnormal_larynx_morphology | 0.33392233 |
| 90 | MP0009672_abnormal_birth_weight | 0.33360545 |
| 91 | MP0005165_increased_susceptibility_to | 0.31958965 |
| 92 | MP0005451_abnormal_body_composition | 0.31086816 |
| 93 | MP0004858_abnormal_nervous_system | 0.30319301 |
| 94 | MP0002089_abnormal_postnatal_growth/wei | 0.29841003 |
| 95 | MP0002909_abnormal_adrenal_gland | 0.29321768 |
| 96 | MP0005423_abnormal_somatic_nervous | 0.29284159 |
| 97 | MP0002876_abnormal_thyroid_physiology | 0.27124488 |
| 98 | MP0005535_abnormal_body_temperature | 0.26899612 |
| 99 | MP0006276_abnormal_autonomic_nervous | 0.26533839 |
| 100 | MP0005332_abnormal_amino_acid | 0.25813756 |
| 101 | MP0001849_ear_inflammation | 0.25582870 |
| 102 | MP0005376_homeostasis/metabolism_phenot | 0.23471026 |
| 103 | MP0002114_abnormal_axial_skeleton | 0.23007891 |
| 104 | MP0002118_abnormal_lipid_homeostasis | 0.22891484 |
| 105 | MP0000767_abnormal_smooth_muscle | 0.22010172 |
| 106 | MP0004197_abnormal_fetal_growth/weight/ | 0.21719701 |
| 107 | MP0002925_abnormal_cardiovascular_devel | 0.21291711 |
| 108 | MP0000579_abnormal_nail_morphology | 0.20401369 |
| 109 | MP0002970_abnormal_white_adipose | 0.19951062 |
| 110 | MP0003279_aneurysm | 0.19801914 |
| 111 | MP0005166_decreased_susceptibility_to | 0.19440554 |
| 112 | MP0001784_abnormal_fluid_regulation | 0.18993599 |
| 113 | MP0003941_abnormal_skin_development | 0.18600558 |
| 114 | MP0004142_abnormal_muscle_tone | 0.18093281 |
| 115 | MP0001943_abnormal_respiration | 0.17803547 |
| 116 | MP0005076_abnormal_cell_differentiation | 0.17547408 |
| 117 | MP0003566_abnormal_cell_adhesion | 0.17528102 |
| 118 | MP0005410_abnormal_fertilization | 0.16736184 |
| 119 | * MP0002066_abnormal_motor_capabilities/c | 0.16542289 |
| 120 | MP0009703_decreased_birth_body | 0.16084871 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Muscle fiber inclusion bodies (HP:0100299) | 9.44896267 |
| 2 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 9.05641468 |
| 3 | Exercise-induced myalgia (HP:0003738) | 8.89348116 |
| 4 | Nemaline bodies (HP:0003798) | 8.42926068 |
| 5 | Exercise-induced muscle cramps (HP:0003710) | 8.13085620 |
| 6 | Muscle hypertrophy of the lower extremities (HP:0008968) | 7.25851899 |
| 7 | Type 1 muscle fiber predominance (HP:0003803) | 7.03192841 |
| 8 | Distal arthrogryposis (HP:0005684) | 6.66733595 |
| 9 | Calf muscle hypertrophy (HP:0008981) | 6.64403692 |
| 10 | Myopathic facies (HP:0002058) | 6.23267052 |
| 11 | Muscle fiber splitting (HP:0003555) | 5.73412901 |
| 12 | Round ear (HP:0100830) | 5.66510337 |
| 13 | Difficulty running (HP:0009046) | 5.64423873 |
| 14 | Myoglobinuria (HP:0002913) | 5.54894908 |
| 15 | Ulnar deviation of the wrist (HP:0003049) | 5.50194320 |
| 16 | Hyporeflexia of lower limbs (HP:0002600) | 5.25133701 |
| 17 | EMG: myopathic abnormalities (HP:0003458) | 4.87390129 |
| 18 | Calcaneovalgus deformity (HP:0001848) | 4.71834502 |
| 19 | Increased connective tissue (HP:0009025) | 4.63496505 |
| 20 | Rhabdomyolysis (HP:0003201) | 4.62306897 |
| 21 | Abnormality of the calf musculature (HP:0001430) | 4.60596010 |
| 22 | Absent phalangeal crease (HP:0006109) | 4.39803292 |
| 23 | Deformed tarsal bones (HP:0008119) | 4.29245444 |
| 24 | Subaortic stenosis (HP:0001682) | 4.09512287 |
| 25 | Abnormality of the left ventricular outflow tract (HP:0011103) | 4.09512287 |
| 26 | Abnormality of skeletal muscle fiber size (HP:0012084) | 3.88200630 |
| 27 | * Muscle stiffness (HP:0003552) | 3.87915536 |
| 28 | Sudden death (HP:0001699) | 3.77104834 |
| 29 | Abnormal finger flexion creases (HP:0006143) | 3.65743767 |
| 30 | Difficulty climbing stairs (HP:0003551) | 3.60342229 |
| 31 | Increased variability in muscle fiber diameter (HP:0003557) | 3.52853997 |
| 32 | Neck muscle weakness (HP:0000467) | 3.52588341 |
| 33 | Rimmed vacuoles (HP:0003805) | 3.46651324 |
| 34 | Asymmetric septal hypertrophy (HP:0001670) | 3.30745026 |
| 35 | Areflexia of lower limbs (HP:0002522) | 3.28396122 |
| 36 | Frequent falls (HP:0002359) | 3.16787467 |
| 37 | * Myotonia (HP:0002486) | 3.15354010 |
| 38 | Pelvic girdle muscle weakness (HP:0003749) | 3.03930116 |
| 39 | Shoulder girdle muscle weakness (HP:0003547) | 2.97624799 |
| 40 | Abnormality of the hip-girdle musculature (HP:0001445) | 2.96818199 |
| 41 | Abnormality of the musculature of the pelvis (HP:0001469) | 2.96818199 |
| 42 | Ventricular tachycardia (HP:0004756) | 2.81963115 |
| 43 | Abnormality of the calcaneus (HP:0008364) | 2.80389832 |
| 44 | Distal lower limb muscle weakness (HP:0009053) | 2.70188849 |
| 45 | EMG: neuropathic changes (HP:0003445) | 2.63390780 |
| 46 | * Malignant hyperthermia (HP:0002047) | 2.55701314 |
| 47 | Muscular dystrophy (HP:0003560) | 2.46072951 |
| 48 | Facial diplegia (HP:0001349) | 2.40357344 |
| 49 | Slender build (HP:0001533) | 2.40323629 |
| 50 | Generalized muscle weakness (HP:0003324) | 2.36925130 |
| 51 | Proximal amyotrophy (HP:0007126) | 2.36287420 |
| 52 | Hypoplastic ischia (HP:0003175) | 2.35177798 |
| 53 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.33856351 |
| 54 | Limb-girdle muscle weakness (HP:0003325) | 2.31586446 |
| 55 | Limb-girdle muscle atrophy (HP:0003797) | 2.31356632 |
| 56 | Lipoatrophy (HP:0100578) | 2.27696586 |
| 57 | Bulbar palsy (HP:0001283) | 2.27322519 |
| 58 | Popliteal pterygium (HP:0009756) | 2.25849491 |
| 59 | Gowers sign (HP:0003391) | 2.21087605 |
| 60 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.18533606 |
| 61 | Distal lower limb amyotrophy (HP:0008944) | 2.18329772 |
| 62 | Scapular winging (HP:0003691) | 2.12284265 |
| 63 | Progressive muscle weakness (HP:0003323) | 2.10113717 |
| 64 | Dilated cardiomyopathy (HP:0001644) | 2.09068433 |
| 65 | Weak cry (HP:0001612) | 2.08459374 |
| 66 | Abnormality of the ischium (HP:0003174) | 2.04830194 |
| 67 | Long clavicles (HP:0000890) | 2.03991462 |
| 68 | Abnormality of the shoulder girdle musculature (HP:0001435) | 2.02940654 |
| 69 | Spinal rigidity (HP:0003306) | 2.01908722 |
| 70 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 2.01573154 |
| 71 | Nonprogressive disorder (HP:0003680) | 1.95193205 |
| 72 | Bundle branch block (HP:0011710) | 1.91514129 |
| 73 | Type 2 muscle fiber atrophy (HP:0003554) | 1.91195125 |
| 74 | Waddling gait (HP:0002515) | 1.81101596 |
| 75 | Muscle fiber atrophy (HP:0100295) | 1.78784187 |
| 76 | Ulnar deviation of finger (HP:0009465) | 1.78357142 |
| 77 | Metatarsus adductus (HP:0001840) | 1.75060211 |
| 78 | Fetal akinesia sequence (HP:0001989) | 1.75003319 |
| 79 | Increased density of long bones (HP:0006392) | 1.73143969 |
| 80 | Right ventricular cardiomyopathy (HP:0011663) | 1.71736629 |
| 81 | Palpitations (HP:0001962) | 1.69349199 |
| 82 | Atrial fibrillation (HP:0005110) | 1.69011532 |
| 83 | Achilles tendon contracture (HP:0001771) | 1.68649398 |
| 84 | Hip contracture (HP:0003273) | 1.68565563 |
| 85 | Oligomenorrhea (HP:0000876) | 1.67123105 |
| 86 | Cholelithiasis (HP:0001081) | 1.66165033 |
| 87 | Abnormality of placental membranes (HP:0011409) | 1.63896490 |
| 88 | Amniotic constriction ring (HP:0009775) | 1.63896490 |
| 89 | Lower limb amyotrophy (HP:0007210) | 1.61183073 |
| 90 | * Abnormality of the neuromuscular junction (HP:0003398) | 1.58514308 |
| 91 | Heart block (HP:0012722) | 1.58352255 |
| 92 | Ragged-red muscle fibers (HP:0003200) | 1.57839052 |
| 93 | Primary atrial arrhythmia (HP:0001692) | 1.56817678 |
| 94 | * Hyperkalemia (HP:0002153) | 1.56810090 |
| 95 | Ventricular arrhythmia (HP:0004308) | 1.56664843 |
| 96 | Exercise intolerance (HP:0003546) | 1.55453086 |
| 97 | Limited hip movement (HP:0008800) | 1.54514274 |
| 98 | Respiratory insufficiency due to muscle weakness (HP:0002747) | 1.52854422 |
| 99 | Foot dorsiflexor weakness (HP:0009027) | 1.52671386 |
| 100 | Increased purine levels (HP:0004368) | 1.52424460 |
| 101 | Hyperuricemia (HP:0002149) | 1.52424460 |
| 102 | Easy fatigability (HP:0003388) | 1.51504346 |
| 103 | Abnormality of the Achilles tendon (HP:0005109) | 1.51309449 |
| 104 | Prolonged QT interval (HP:0001657) | 1.51068040 |
| 105 | Supraventricular tachycardia (HP:0004755) | 1.50327825 |
| 106 | Abnormal atrioventricular conduction (HP:0005150) | 1.49555027 |
| 107 | Abnormality of the foot musculature (HP:0001436) | 1.48125317 |
| 108 | Short palpebral fissure (HP:0012745) | 1.47262221 |
| 109 | Supraventricular arrhythmia (HP:0005115) | 1.46599929 |
| 110 | Toxemia of pregnancy (HP:0100603) | 1.45010440 |
| 111 | * Fatigable weakness (HP:0003473) | 1.44838405 |
| 112 | Increased muscle lipid content (HP:0009058) | 1.36818968 |
| 113 | Ulnar deviation of the hand or of fingers of the hand (HP:0001193) | 1.36621556 |
| 114 | Breech presentation (HP:0001623) | 1.35859306 |
| 115 | Increased intramyocellular lipid droplets (HP:0012240) | 1.34703070 |
| 116 | Steppage gait (HP:0003376) | 1.33808271 |
| 117 | Congenital hip dislocation (HP:0001374) | 1.31918760 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | OBSCN | 8.10236171 |
| 2 | TTN | 6.62623711 |
| 3 | PHKG1 | 5.59465786 |
| 4 | PHKG2 | 5.59465786 |
| 5 | NME1 | 3.72005632 |
| 6 | PIK3CG | 3.17735111 |
| 7 | MAP2K3 | 2.69762659 |
| 8 | NEK1 | 2.23348406 |
| 9 | TRIB3 | 2.22996094 |
| 10 | MAP3K7 | 2.14606654 |
| 11 | DMPK | 2.14136738 |
| 12 | PDK3 | 2.13713063 |
| 13 | PDK4 | 2.13713063 |
| 14 | PINK1 | 2.13325198 |
| 15 | PIK3CA | 1.73419075 |
| 16 | BCKDK | 1.70224624 |
| 17 | MAPK12 | 1.67885438 |
| 18 | MUSK | 1.61572119 |
| 19 | PDK2 | 1.33543977 |
| 20 | MAP2K4 | 1.28100431 |
| 21 | MAP2K6 | 1.16359907 |
| 22 | PKN2 | 1.14913261 |
| 23 | MOS | 1.11424174 |
| 24 | MARK1 | 0.96885224 |
| 25 | PRKAA2 | 0.95240058 |
| 26 | MAPKAPK3 | 0.92689396 |
| 27 | PRKAA1 | 0.91283849 |
| 28 | CCNB1 | 0.88642913 |
| 29 | STK24 | 0.88437387 |
| 30 | MAP3K3 | 0.82528390 |
| 31 | MAP3K10 | 0.82467288 |
| 32 | NEK9 | 0.81228636 |
| 33 | MAP3K13 | 0.78455574 |
| 34 | TRPM7 | 0.69556922 |
| 35 | ZAK | 0.67293217 |
| 36 | EPHB1 | 0.61696362 |
| 37 | SIK1 | 0.59665173 |
| 38 | EEF2K | 0.58596961 |
| 39 | AKT2 | 0.58398261 |
| 40 | MAPK11 | 0.58325717 |
| 41 | TIE1 | 0.55555302 |
| 42 | TAOK2 | 0.54452007 |
| 43 | CAMK1 | 0.54118664 |
| 44 | LMTK2 | 0.52860456 |
| 45 | ILK | 0.51472554 |
| 46 | LATS2 | 0.50697245 |
| 47 | RIPK1 | 0.47958318 |
| 48 | TAOK1 | 0.47446662 |
| 49 | PRKD1 | 0.46397253 |
| 50 | CAMK2G | 0.46089911 |
| 51 | PKN1 | 0.45308310 |
| 52 | ERBB3 | 0.43500142 |
| 53 | PTK6 | 0.42982476 |
| 54 | MAP3K5 | 0.42399886 |
| 55 | MAP3K11 | 0.40456777 |
| 56 | ERN1 | 0.37311627 |
| 57 | CAMK2A | 0.34233788 |
| 58 | CAMK2B | 0.32727903 |
| 59 | ROCK1 | 0.32658813 |
| 60 | SGK2 | 0.31959813 |
| 61 | MARK2 | 0.31018903 |
| 62 | LRRK2 | 0.30974889 |
| 63 | MAPK7 | 0.30856668 |
| 64 | SGK1 | 0.29977355 |
| 65 | TYK2 | 0.29537593 |
| 66 | TGFBR2 | 0.28839306 |
| 67 | RPS6KB1 | 0.27352136 |
| 68 | CAMK2D | 0.27035113 |
| 69 | CAMK1G | 0.26267673 |
| 70 | MAPK10 | 0.25959472 |
| 71 | MYLK | 0.25596443 |
| 72 | MAP4K1 | 0.25552143 |
| 73 | TBK1 | 0.24381658 |
| 74 | INSRR | 0.23671939 |
| 75 | PRKG1 | 0.23243494 |
| 76 | PRPF4B | 0.23184722 |
| 77 | PDK1 | 0.22072369 |
| 78 | MAPK4 | 0.22029661 |
| 79 | RPS6KB2 | 0.21822644 |
| 80 | PRKACA | 0.21434800 |
| 81 | MAP3K1 | 0.21302036 |
| 82 | PDPK1 | 0.20857287 |
| 83 | MAP3K6 | 0.20279683 |
| 84 | ICK | 0.19023909 |
| 85 | LATS1 | 0.18666425 |
| 86 | JAK1 | 0.18289083 |
| 87 | NLK | 0.17819339 |
| 88 | * RPS6KA3 | 0.17484251 |
| 89 | ARAF | 0.16721858 |
| 90 | CDK19 | 0.16361086 |
| 91 | MAP2K1 | 0.16168402 |
| 92 | MAPK13 | 0.15427220 |
| 93 | SGK223 | 0.15366956 |
| 94 | SGK494 | 0.15366956 |
| 95 | SGK3 | 0.14530148 |
| 96 | KSR2 | 0.13770561 |
| 97 | FLT3 | 0.13614021 |
| 98 | DYRK1B | 0.13514622 |
| 99 | RPS6KA1 | 0.13513328 |
| 100 | MTOR | 0.13169685 |
| 101 | * PRKACB | 0.12519548 |
| 102 | ROCK2 | 0.12449531 |
| 103 | WNK1 | 0.11448931 |
| 104 | DDR2 | 0.10904131 |
| 105 | MARK3 | 0.10610304 |
| 106 | PRKACG | 0.10279204 |
| 107 | RPS6KA6 | 0.10241159 |
| 108 | TESK1 | 0.09324106 |
| 109 | STK11 | 0.09145307 |
| 110 | JAK2 | 0.08480601 |
| 111 | PRKCH | 0.08101577 |
| 112 | GSK3B | 0.07690607 |
| 113 | KDR | 0.07472853 |
| 114 | DAPK2 | 0.07116064 |
| 115 | HCK | 0.07108376 |
| 116 | ZAP70 | 0.06495742 |
| 117 | BRAF | 0.06462827 |
| 118 | MAPK9 | 0.06326623 |
| 119 | MAP3K9 | 0.06253229 |
| 120 | LIMK1 | 0.05173182 |
| 121 | CSNK1D | 0.04673570 |
| 122 | RPS6KA2 | 0.03669137 |
| 123 | CAMK4 | 0.03063091 |
| 124 | MAPK8 | 0.02479843 |
| 125 | PAK6 | 0.02239451 |
| 126 | FGFR3 | 0.02167695 |
| 127 | PAK3 | 0.02115000 |
| 128 | RPS6KL1 | 0.01908717 |
| 129 | RPS6KC1 | 0.01908717 |
| 130 | CDC42BPA | 0.01678480 |
| 131 | PTK2B | 0.01665100 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 4.76495657 |
| 2 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 4.32177302 |
| 3 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 3.83329945 |
| 4 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 3.70143394 |
| 5 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 3.62635413 |
| 6 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 3.43710092 |
| 7 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.86348595 |
| 8 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.59097217 |
| 9 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 2.48247881 |
| 10 | Carbon metabolism_Homo sapiens_hsa01200 | 2.22463941 |
| 11 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 2.17459308 |
| 12 | Insulin signaling pathway_Homo sapiens_hsa04910 | 2.08057566 |
| 13 | Insulin resistance_Homo sapiens_hsa04931 | 2.04116828 |
| 14 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.91834886 |
| 15 | Circadian rhythm_Homo sapiens_hsa04710 | 1.91463439 |
| 16 | Parkinsons disease_Homo sapiens_hsa05012 | 1.91223720 |
| 17 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.82321979 |
| 18 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.78030122 |
| 19 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.76822106 |
| 20 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.74886835 |
| 21 | Viral myocarditis_Homo sapiens_hsa05416 | 1.73797529 |
| 22 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.70454044 |
| 23 | Alzheimers disease_Homo sapiens_hsa05010 | 1.70236571 |
| 24 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.62362432 |
| 25 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.56109291 |
| 26 | AMPK signaling pathway_Homo sapiens_hsa04152 | 1.55817256 |
| 27 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.49792299 |
| 28 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.44444947 |
| 29 | Galactose metabolism_Homo sapiens_hsa00052 | 1.36683099 |
| 30 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 1.31717670 |
| 31 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.28301306 |
| 32 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.23980576 |
| 33 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.23972362 |
| 34 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.21668373 |
| 35 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.06189260 |
| 36 | Tight junction_Homo sapiens_hsa04530 | 1.00237813 |
| 37 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.00012167 |
| 38 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.97233799 |
| 39 | Focal adhesion_Homo sapiens_hsa04510 | 0.95267190 |
| 40 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.92491686 |
| 41 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.91443010 |
| 42 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.88027084 |
| 43 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.86472464 |
| 44 | Huntingtons disease_Homo sapiens_hsa05016 | 0.85279847 |
| 45 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.85186119 |
| 46 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.84443944 |
| 47 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.82059400 |
| 48 | Long-term potentiation_Homo sapiens_hsa04720 | 0.79657873 |
| 49 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.78614134 |
| 50 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.77487221 |
| 51 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.73818526 |
| 52 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.72242514 |
| 53 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.71223860 |
| 54 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.69823457 |
| 55 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.66090989 |
| 56 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.66049112 |
| 57 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.64715487 |
| 58 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.62394525 |
| 59 | Renin secretion_Homo sapiens_hsa04924 | 0.61771732 |
| 60 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.61593220 |
| 61 | Platelet activation_Homo sapiens_hsa04611 | 0.57528535 |
| 62 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.57264684 |
| 63 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.52390798 |
| 64 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.46430692 |
| 65 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.45669802 |
| 66 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.44058513 |
| 67 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.43320683 |
| 68 | Insulin secretion_Homo sapiens_hsa04911 | 0.42521910 |
| 69 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.40789707 |
| 70 | Histidine metabolism_Homo sapiens_hsa00340 | 0.38916147 |
| 71 | Lysine degradation_Homo sapiens_hsa00310 | 0.38783268 |
| 72 | Salivary secretion_Homo sapiens_hsa04970 | 0.38514923 |
| 73 | Adherens junction_Homo sapiens_hsa04520 | 0.38359834 |
| 74 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.37970468 |
| 75 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.36492734 |
| 76 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.36427385 |
| 77 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.34807177 |
| 78 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.34563877 |
| 79 | Amoebiasis_Homo sapiens_hsa05146 | 0.33311790 |
| 80 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.33087441 |
| 81 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.30734981 |
| 82 | Glioma_Homo sapiens_hsa05214 | 0.26762294 |
| 83 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.25202726 |
| 84 | Thyroid cancer_Homo sapiens_hsa05216 | 0.22460769 |
| 85 | Melanogenesis_Homo sapiens_hsa04916 | 0.22204781 |
| 86 | Purine metabolism_Homo sapiens_hsa00230 | 0.20863598 |
| 87 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.20859604 |
| 88 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.20524489 |
| 89 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.20046884 |
| 90 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.19586972 |
| 91 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.19256755 |
| 92 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.19082685 |
| 93 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.18876223 |
| 94 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.17516769 |
| 95 | Olfactory transduction_Homo sapiens_hsa04740 | 0.17364033 |
| 96 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.16562950 |
| 97 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.16387337 |
| 98 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.16053798 |
| 99 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.15946354 |
| 100 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.15890503 |
| 101 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.15160121 |
| 102 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.14475132 |
| 103 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.14408163 |
| 104 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.13983365 |
| 105 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.12546813 |
| 106 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.12187408 |
| 107 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.11962602 |
| 108 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.10596822 |
| 109 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.10010381 |
| 110 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.09980158 |
| 111 | Sulfur relay system_Homo sapiens_hsa04122 | 0.09567111 |
| 112 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.09287461 |
| 113 | Circadian entrainment_Homo sapiens_hsa04713 | 0.09195319 |
| 114 | Peroxisome_Homo sapiens_hsa04146 | 0.06902108 |
| 115 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.06494386 |
| 116 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.05890874 |
| 117 | Leishmaniasis_Homo sapiens_hsa05140 | 0.05399988 |
| 118 | Long-term depression_Homo sapiens_hsa04730 | 0.04765521 |
| 119 | ABC transporters_Homo sapiens_hsa02010 | 0.04182136 |
| 120 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.03755867 |
| 121 | Metabolic pathways_Homo sapiens_hsa01100 | 0.02784965 |

